Discover 3,086 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,086
Active & Responsive
Assessment of CCM in HF With Higher Ejection Fraction
for
Heart Failure, Heart Failure With Preserved Ejection Fraction,
Location: Boston MA, Hartford CT, Danbury CT, Poughkeepsie NY,
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT04363684
Recruiting
Active & ResponsiveNew
Leveraging Interventions for Caregiver Growth, Health, Training, Empowerment and Navigation: Comparing Group Behavioral Interventions to Improve Dementia Caregiver Strain
Location: Boston MA, Chicago IL, Rochester MN, Stanford CA
Sponsor: Duke University
Sex: All
Age: 21 - 70+
Code: NCT07567794
Recruiting
Active & Responsive
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
for
Coronary Artery Disease Risk Factors Multiple,
Location: Boston MA, New York NY, Pittsburgh PA,
Sponsor: Duke University
Sex: All
Age: 30 - 60
Code: NCT07232069
Phase 3, Recruiting
Active & Responsive
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
for
Unresectable or Metastatic Hepatocellular Carcinoma,
Location: Boston MA, Atlanta GA, Peoria IL, Orange CA, Irvine CA,
Sponsor: CatalYm GmbH
Sex: All
Age: 18 - 70+
Code: NCT07219459
Phase 2, Recruiting
Active & Responsive
PrP-targeting siRNA Safety & Mechanism Study
for
Prion Disease
Location: Boston MA, New York NY, Cleveland OH, Nashville TN,
Sponsor: Broad Institute of MIT and Harvard
Sex: All
Age: 18+
Code: NCT07444580
Phase 1, Recruiting
Active & Responsive
A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement
for
FGFR2 Gene Fusion/Rearrangement, Other Solid Tumors, Adult
Location: Boston MA, New York NY, Chicago IL, Tampa FL,
Sponsor: Elevar Therapeutics
Sex: All
Age: 18+
Code: NCT07359820
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
for
Multiple Myeloma in Relapse, Myeloma Multiple,
Location: Boston MA, Hackensack NJ, Atlanta GA, Tampa FL,